GENSIGHT BIOLOGICS Stock Went Down By Over 32% In The Last 21 Sessions
(VIANEWS) – Shares of GENSIGHT BIOLOGICS (CAC 40: SIGHT.PA) dropped by a staggering 32.65% in 21 sessions from €3.4 to €2.29 at 13:59 EST on Thursday, after three successive sessions in a row of losses. CAC 40 is rising 1.11% to €6,962.11, following the last session’s downward trend. About GENSIGHT BIOLOGICS GenSight Biologics S.A., a…